POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 102 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,491,804 | +63.8% | 3,567,985 | +21.1% | 2.58% | +60.5% |
| Q2 2023 | $5,184,868 | -37.4% | 2,945,948 | +9.5% | 1.60% | -53.1% |
| Q1 2023 | $8,283,047 | -29.9% | 2,689,301 | +20.6% | 3.42% | +1.1% |
| Q4 2022 | $11,819,000 | +31.1% | 2,230,000 | -12.7% | 3.38% | +10.9% |
| Q3 2022 | $9,017,000 | +818.2% | 2,554,277 | +571.1% | 3.05% | +909.9% |
| Q2 2022 | $982,000 | -8.6% | 380,606 | +58.8% | 0.30% | -32.0% |
| Q1 2022 | $1,074,000 | -32.9% | 239,696 | +2.0% | 0.44% | -31.5% |
| Q4 2021 | $1,600,000 | – | 234,932 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $10,454,000 | 1.67% |
| Boxer Capital, LLC | 1,251,055 | $12,536,000 | 0.44% |
| Pentwater Capital Management LP | 4,967,227 | $49,772,000 | 0.41% |
| KNOTT DAVID M | 29,566 | $296,000 | 0.10% |
| Perceptive Advisors | 1,575,490 | $15,786,000 | 0.10% |
| Virtus ETF Advisers LLC | 24,287 | $243,000 | 0.10% |
| Advisory Services Network, LLC | 256,772 | $2,573,000 | 0.08% |
| J. Goldman & Co LP | 202,501 | $2,029,000 | 0.08% |
| Ikarian Capital, LLC | 85,837 | $861,000 | 0.07% |
| Regent Investment Management LLC | 25,000 | $251,000 | 0.06% |